Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy

International Journal of Infectious Diseases

Volumn 15, Issue 8, 2011, Pages

  Li Cavoli, Gioacchino ^a   Ferrantelli, Angelo ^a   Bono, Luisa ^a   Tortorici, Calogera ^a   Giammarresi, Carlo ^a   Zagarrigo, Carmela ^a   Schillaci, Onofrio ^a   Tralongo, Angelo ^a   Soresi, Maurizio ^b   Rotolo, Ugo ^a  

^a Civic and Di Cristina Hospital   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Chronic kidney disease; HCV infection; Prevalence of infection

Indexed keywords

VIRUS RNA;

AGED; BLOOD TRANSFUSION; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DIALYSIS; EUROPE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; ITALY; LIVER FUNCTION TEST; MAJOR SURGERY; MALE; POPULATION; SHORT SURVEY;

AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; PUBLIC HEALTH; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RNA, VIRAL; SICILY;

EID: 79961028527     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.04.001     Document Type: Short Survey

References (7)

1. Centers for Disease Control and Prevention Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001, 50:1-43.
2. Esteban J.I., Sauleda S., Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008, 48:148-162.
3. Covic A., Abramowicz D., Bruchfeld A., Leroux-Roels G., Samuel D., van Biesen W., et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Best Practice (ERBP) position statement. Nephrol Dial Transplant 2009, 24:719-727.
4. Fissell R.B., Bragg-Gresham J.L., Woods J.D., Jadoul M., Gillespie B., Hedderwick S.A., et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004, 65:2335-2342.
5. Fabrizi F., Marcelli D., Bacchini G., Guarnori I., Erba G., Locatelli F., et al. Antibodies to hepatitis C virus in chronic renal failure patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Nephrol Dial Transplant 1994, 9:780-784.
6. Bergman S., Accort N., Turner A., Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 2005, 45:684-689.
7. Lemos L.B., Perez R.M., Lemos M.M. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients. Nephron Clin Pract 2008, 108. c135-c140.